Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Registre HEAR, Healthcare European Amyloidosis Registry

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a non-interventional, prospective, retrospective, non-comparative, multi-center study. In order not to interfere with patient management, the study is observational. Thus, no follow-up visit is imposed. The data collection will be limited to the data related to the management of the patients included throughout their follow-up. This study is intended for all patients with a confirmed or suspected diagnosis of cardiac amyloidosis. Three cohorts will be identified: the HEAR (Healthcare European Amyloidosis Registry)-Retrospective Cohort, the HEAR(Healthcare European Amyloidosis Registry)-Retrospective-Prospective Cohort and the HEAR (Healthcare European Amyloidosis Registry)-Prospective Cohort.

Who May Be Eligible (Plain English)

INCLUSION CRITERIA 1. Patients must meet all of the following inclusion criteria to be included in the study: - Major patient - Protected adult patient (guardianship or curatorship) 2. Prospective Cohort: Patients referred or who have been referred to the participating centre for suspected amyloidosis. Patient who signed the patient information "Prospective Cohort" note 3. Retro-prospective Cohort: Patient already followed in the center with a confirmed diagnosis of amyloidosis Patient who signed the "retro-prospective cohort" patient information note 4. Retrospective cohort: Deceased patients followed in the center with a confirmed diagnosis of amyloidosis Study participants will not be compensated for their participation EXCLUSION CRITERIA The patient has expressed his/her refusal to participate Participation in another study, even an interventional one, is not a criterion for non-inclusion. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
INCLUSION CRITERIA 1. Patients must meet all of the following inclusion criteria to be included in the study: * Major patient * Protected adult patient (guardianship or curatorship) 2. Prospective Cohort: Patients referred or who have been referred to the participating centre for suspected amyloidosis. Patient who signed the patient information "Prospective Cohort" note 3. Retro-prospective Cohort: Patient already followed in the center with a confirmed diagnosis of amyloidosis Patient who signed the "retro-prospective cohort" patient information note 4. Retrospective cohort: Deceased patients followed in the center with a confirmed diagnosis of amyloidosis Study participants will not be compensated for their participation EXCLUSION CRITERIA The patient has expressed his/her refusal to participate Participation in another study, even an interventional one, is not a criterion for non-inclusion.

Locations (1)

Hôpital Henri Mondor
Créteil, France